Proper disposal and accountability are essential for used, unused, and expired clinical trial materials and Investigational Medicinal Products (IMPs), in adherence to Good Clinical Practice (GCP) guidelines with a destruction certificate. IMP is equipped to manage all the necessary services related to returns, reconciliation, and destruction using GMP/GCP-compliant procedures.
Our personnel work in coordination with the investigational site and study team. Returned materials undergo a meticulous accountability process and are securely stored in a dedicated area. When necessary, destruction is carried out and accompanied by a destruction certificate.
IMP also offers temperature-controlled, QP released, return shipments for ability to re-use the drug products when needed.